Clinical Trial

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 29, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to test how safe and effective it is to treat early form of cancer cells found in the upper skin layer of the face, using a light-sensitive gel used in combination with a light source. The main questions this trial aims to answer are: * to confirm using laboratory testing, how much of the affected facial skin cancer section the treatment was able to remove, and; * seeing how many participants had no remaining affected facial skin cancer sections after treatment. Participants who qualify will be asked to complete 14 visits in total and will receive a total of two treatments, after voluntarily consent has been given.
Trial Details
NCT Number NCT06577311
Lead Sponsor The Center for Clinical and Cosmetic Research
Collaborators: Biofrontera Inc.
Conditions Cutaneous Squamous Cell Carcinoma
Enrollment 20 participants
Start Date 2024-08-14
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2024-08-29